Advaxis, Inc. (ADXS) Represents the New War Against Cancer And Infectious Disease
The ongoing battle against cancer and infectious diseases in the human body has been compared many times to a type of war, involving strategies that are more alike than one might expect. The fight against cancer is a prime example. It is much like a war against infiltrating terrorists, with evolving strategies being developed as the threat is first recognized, then analyzed, and finally attacked in a variety of ways.
In the case of terrorists infiltrating a foreign country, a threat can exist long before it is finally recognized. Terrorists enter a country surreptitiously, recruiting others, growing in numbers and strength, all before enough damage is done inside or outside to trigger an alert. Once it becomes clear that something is seriously wrong, the nature and size of the threat must be more clearly determined. Only then can meaningful action be taken, and the longer it takes to recognize and analyze what is happening, the more damage can occur.
In the case of war, military action may take the form of high level bombing, but that invariably causes what is euphemistically called collateral damage, where good people are getting hurt or killed along with the bad. In the end, the best solution is to have maximum “intelligence on the ground,” where trained identification and action can be taken on a localized and high-precision basis, projecting the greatest power against exactly the correct targets.
In the case of cancer, a malignancy can begin and develop for some time, with few if any obvious symptoms, emphasizing the importance of early diagnosis. Once a problem is felt, a more exact diagnosis is needed to pinpoint the nature of the cancer. At that point radiation and chemotherapy is often applied, where finely tuned rays or chemical poisons are administered. It’s analogous to high-level bombing, since, in spite of advances in technology, many good cells and structures can get damaged or destroyed along with the cancer cells.
Immunotherapy, such as that being developed by Advaxis, represents the medical version of intelligence on the ground, where an individual’s own immune system is, in effect, trained to search out and destroy the bad cells. Everything is done at the cellular level, where effectiveness can be maximized, and collateral damage can be minimized or even eliminated. It is seen by many as the ideal solution, and the next big step in the treatment of cancer and infectious diseases. Advaxis is already developing a pipeline of immunotherapy products for cervical cancer, head and neck cancer, and other cancers, winning awards for their revolutionary developments.
For additional information, visit www.Advaxis.com
Please see disclaimer on the QualityStocks website: http://Disclaimer.QualityStocks.net